{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:35:54Z","timestamp":1791326154437,"version":"4.3.1"},"reference-count":63,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tumor necrosis factor (TNF) superfamily members BAFF, or B-cell activation factor of the TNF family, and APRIL, a proliferation-inducing ligand, are involved in normal B-cell survival and differentiation. They interact with 3 receptors: BAFF-R, specific to BAFF; and TACI and BCMA, which are shared by BAFF and APRIL. We tested the potential role of these proteins in B-cell chronic lymphocytic leukemia (B-CLL) resistance to apoptosis. TACI and BAFF-R mRNAs were found in leukemic B cells. BAFF and APRIL mRNAs and proteins were detected in B-CLL leukemic cells and normal blood or tonsil-derived B lymphocytes. Yet, in contrast to normal B lymphocytes, BAFF and APRIL were expressed at the membranes of leukemic cells. Adding soluble BAFF or APRIL protected B-CLL cells against spontaneous and drug-induced apoptosis and stimulated NF-\u03baB activation. Conversely, adding soluble BCMA-Fc or anti-BAFF and anti-APRIL antibodies enhanced B-CLL apoptosis. Moreover, a soluble form of BAFF was detected using surface-enhanced laser desorption\/ionization\u2013time-of-flight mass spectrometry (SELDI-TOF MS) in the sera of B-CLL patients but not of healthy donors. Taken together, our results indicate that B-CLL cells can be rescued from apoptosis through an autocrine process involving BAFF, APRIL, and their receptors. Inhibiting BAFF and APRIL pathways may be of therapeutic value for B-CLL treatment.<\/jats:p>","DOI":"10.1182\/blood-2003-02-0540","type":"journal-article","created":{"date-parts":[[2003,9,23]],"date-time":"2003-09-23T01:36:27Z","timestamp":1064280987000},"page":"679-688","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":251,"title":["Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway"],"prefix":"10.1182","volume":"103","author":[{"given":"Catherine","family":"Kern","sequence":"first","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Franc\u0327ois","family":"Cornuel","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Billard","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoping","family":"Tang","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Rouillard","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Stenou","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Defrance","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Ajchenbaum-Cymbalista","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Simonin","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Feldblum","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Kolb","sequence":"additional","affiliation":[{"name":"From the U365 Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM), Institut Curie, Paris, France; Neurolab, Paris, France; EA1529\/EMI9912, Service d'He\u0301matologie, Paris, France; Service de Cytome\u0301trie, Institut Curie, Paris, France; and U404 INSERM, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218525656000_REF1","doi-asserted-by":"crossref","unstructured":"Bannerji R, Byrd JC. Update on the biology of chronic lymphocytic leukemia. Curr Opin Oncol. 2000;12: 22-29.","DOI":"10.1097\/00001622-200001000-00004"},{"key":"2020021218525656000_REF2","unstructured":"Keating MJ. Chronic lymphocytic leukemia. Semin Oncol. 1999;26: 107-114."},{"key":"2020021218525656000_REF3","doi-asserted-by":"crossref","unstructured":"Decker T, Hipp S, Ringshausen I, et al. Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood. 2003;101: 278-285.","DOI":"10.1182\/blood-2002-01-0189"},{"key":"2020021218525656000_REF4","doi-asserted-by":"crossref","unstructured":"Caligaris-Cappio F. Biology of chronic lymphocytic leukemia. Rev Clin Exp Hematol. 2000;4: 5-21.","DOI":"10.1046\/j.1468-0734.2000.00001.x"},{"key":"2020021218525656000_REF5","doi-asserted-by":"crossref","unstructured":"Kolb JP, Kern C, Quiney C, Roman V, Billard C. Re-establishment of a normal apoptotic process as a therapeutic approach in B-CLL. Curr Drug Targets Cardiovasc Haematol Disord. 2003;3: 261-286.","DOI":"10.2174\/1568006033481384"},{"key":"2020021218525656000_REF6","doi-asserted-by":"crossref","unstructured":"Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189: 1747-1756.","DOI":"10.1084\/jem.189.11.1747"},{"key":"2020021218525656000_REF7","doi-asserted-by":"crossref","unstructured":"Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999;285: 260-263.","DOI":"10.1126\/science.285.5425.260"},{"key":"2020021218525656000_REF8","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay A, Ni J, Zhai Y, Yu GL, Aggarwal BB. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c- Jun NH2-terminal kinase. J Biol Chem. 1999;274: 15978-15981.","DOI":"10.1074\/jbc.274.23.15978"},{"key":"2020021218525656000_REF9","doi-asserted-by":"crossref","unstructured":"Shu HB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol. 1999;65: 680-683.","DOI":"10.1002\/jlb.65.5.680"},{"key":"2020021218525656000_REF10","doi-asserted-by":"crossref","unstructured":"Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000;404: 995-999.","DOI":"10.1038\/35010115"},{"key":"2020021218525656000_REF11","doi-asserted-by":"crossref","unstructured":"Hahne M, Kataoka T, Schroter M, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med. 1998; 188: 1185-1190.","DOI":"10.1084\/jem.188.6.1185"},{"key":"2020021218525656000_REF12","unstructured":"Kelly K, Manos E, Jensen G, Nadauld L, Jones DA. APRIL\/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 2000; 60: 1021-1027."},{"key":"2020021218525656000_REF13","doi-asserted-by":"crossref","unstructured":"Mackay F, Ambrose C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev. 2003;14: 311-324.","DOI":"10.1016\/S1359-6101(03)00023-6"},{"key":"2020021218525656000_REF14","doi-asserted-by":"crossref","unstructured":"Nardelli B, Belvedere O, Roschke V, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood. 2001;97: 198-204.","DOI":"10.1182\/blood.V97.1.198"},{"key":"2020021218525656000_REF15","doi-asserted-by":"crossref","unstructured":"Lopez-Fraga M, Fernandez R, Albar JP, Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2001;2: 945-951.","DOI":"10.1093\/embo-reports\/kve198"},{"key":"2020021218525656000_REF16","doi-asserted-by":"crossref","unstructured":"Craxton A, Magaletti D, Ryan EJ, Clark EA. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood. 2003;101: 4464-4471.","DOI":"10.1182\/blood-2002-10-3123"},{"key":"2020021218525656000_REF17","doi-asserted-by":"crossref","unstructured":"Shu HB, Johnson H. B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. Proc Natl Acad Sci U S A. 2000; 97: 9156-9161.","DOI":"10.1073\/pnas.160213497"},{"key":"2020021218525656000_REF18","doi-asserted-by":"crossref","unstructured":"Wu Y, Bressette D, Carrell JA, et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J Biol Chem. 2000; 275: 35478-35485.","DOI":"10.1074\/jbc.M005224200"},{"key":"2020021218525656000_REF19","doi-asserted-by":"crossref","unstructured":"Xia XZ, Treanor J, Senaldi G, et al. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med. 2000;192: 137-143.","DOI":"10.1084\/jem.192.1.137"},{"key":"2020021218525656000_REF20","doi-asserted-by":"crossref","unstructured":"Laabi Y, Gras MP, Carbonnel F, et al. A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. EMBO J. 1992;11: 3897-3904.","DOI":"10.1002\/j.1460-2075.1992.tb05482.x"},{"key":"2020021218525656000_REF21","doi-asserted-by":"crossref","unstructured":"Hatzoglou A, Roussel J, Bourgeade MF, et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J Immunol. 2000;165: 1322-1330.","DOI":"10.4049\/jimmunol.165.3.1322"},{"key":"2020021218525656000_REF22","doi-asserted-by":"crossref","unstructured":"Kanakaraj P, Migone TS, Nardelli B, et al. BLyS binds to B cells with high affinity and induces activation of the transcription factors NF-\u03baB and ELF-1. Cytokine. 2001;13: 25-31.","DOI":"10.1006\/cyto.2000.0793"},{"key":"2020021218525656000_REF23","doi-asserted-by":"crossref","unstructured":"Thompson JS, Bixler SA, Qian F, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001;293: 2108-2111.","DOI":"10.1126\/science.1061965"},{"key":"2020021218525656000_REF24","doi-asserted-by":"crossref","unstructured":"Yan M, Brady JR, Chan B, et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol. 2001;11: 1547-1552.","DOI":"10.1016\/S0960-9822(01)00481-X"},{"key":"2020021218525656000_REF25","unstructured":"Ambrose CM. Baff-R. J Biol Regul Homeost Agents. 2002;16: 211-213."},{"key":"2020021218525656000_REF26","doi-asserted-by":"crossref","unstructured":"Laabi Y, Gras MP, Brouet JC, et al. The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res. 1994;22: 1147-1154.","DOI":"10.1093\/nar\/22.7.1147"},{"key":"2020021218525656000_REF27","doi-asserted-by":"crossref","unstructured":"von Bulow GU, Bram RJ. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science. 1997;278: 138-141.","DOI":"10.1126\/science.278.5335.138"},{"key":"2020021218525656000_REF28","doi-asserted-by":"crossref","unstructured":"Litinskiy MB, Nardelli B, Hilbert DM, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3: 822-829.","DOI":"10.1038\/ni829"},{"key":"2020021218525656000_REF29","doi-asserted-by":"crossref","unstructured":"MacLennan I, Vinuesa C. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity. 2002;17: 235-238.","DOI":"10.1016\/S1074-7613(02)00398-9"},{"key":"2020021218525656000_REF30","doi-asserted-by":"crossref","unstructured":"Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2003;21: 231-264.","DOI":"10.1146\/annurev.immunol.21.120601.141152"},{"key":"2020021218525656000_REF31","doi-asserted-by":"crossref","unstructured":"Batten M, Groom J, Cachero TG, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med. 2000;192: 1453-1466.","DOI":"10.1084\/jem.192.10.1453"},{"key":"2020021218525656000_REF32","doi-asserted-by":"crossref","unstructured":"Khare SD, Sarosi I, Xia XZ, et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A. 2000; 97: 3370-3375.","DOI":"10.1073\/pnas.97.7.3370"},{"key":"2020021218525656000_REF33","doi-asserted-by":"crossref","unstructured":"Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999;190: 1697-1710.","DOI":"10.1084\/jem.190.11.1697"},{"key":"2020021218525656000_REF34","doi-asserted-by":"crossref","unstructured":"Groom J, Kalled SL, Cutler AH, et al. Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest. 2002;109: 59-68.","DOI":"10.1172\/JCI0214121"},{"key":"2020021218525656000_REF35","doi-asserted-by":"crossref","unstructured":"Harless SM, Lentz VM, Sah AP, et al. Competition for BLyS-mediated signaling through Bcmd\/BR3 regulates peripheral B lymphocyte numbers. Curr Biol. 2001;11: 1986-1989.","DOI":"10.1016\/S0960-9822(01)00598-X"},{"key":"2020021218525656000_REF36","doi-asserted-by":"crossref","unstructured":"Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 2001;293: 2111-2114.","DOI":"10.1126\/science.1061964"},{"key":"2020021218525656000_REF37","doi-asserted-by":"crossref","unstructured":"Yu G, Boone T, Delaney J, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol. 2000; 1: 252-256.","DOI":"10.1038\/79802"},{"key":"2020021218525656000_REF38","doi-asserted-by":"crossref","unstructured":"Stein JV, Lopez-Fraga M, Elustondo FA, et al. APRIL modulates B and T cell immunity. J Clin Invest. 2002;109: 1587-1598.","DOI":"10.1172\/JCI0215034"},{"key":"2020021218525656000_REF39","doi-asserted-by":"crossref","unstructured":"Zhao H, Dugas N, Mathiot C, et al. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying antiapoptotic activity. Blood. 1998;92: 1031-1043.","DOI":"10.1182\/blood.V92.3.1031"},{"key":"2020021218525656000_REF40","doi-asserted-by":"crossref","unstructured":"Bauvois B, Dumont J, Mathiot C, Kolb JP. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Leukemia. 2002;16: 791-798.","DOI":"10.1038\/sj.leu.2402472"},{"key":"2020021218525656000_REF41","doi-asserted-by":"crossref","unstructured":"Hennino A, Berard M, Krammer PH, Defrance T. FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis. J Exp Med. 2001; 193: 447-458.","DOI":"10.1084\/jem.193.4.447"},{"key":"2020021218525656000_REF42","doi-asserted-by":"crossref","unstructured":"Hennino A, Berard M, Casamayor-Palleja M, Krammer PH, Defrance T. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells. J Immunol. 2000;165: 3023-3030.","DOI":"10.4049\/jimmunol.165.6.3023"},{"key":"2020021218525656000_REF43","doi-asserted-by":"crossref","unstructured":"Saltman D, Bansal NS, Ross FM, et al. Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement. Leuk Res. 1990;14: 381-387.","DOI":"10.1016\/0145-2126(90)90167-8"},{"key":"2020021218525656000_REF44","doi-asserted-by":"crossref","unstructured":"Roth W, Wagenknecht B, Klumpp A, et al. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Differ. 2001;8: 403-410.","DOI":"10.1038\/sj.cdd.4400827"},{"key":"2020021218525656000_REF45","doi-asserted-by":"crossref","unstructured":"Novak AJ, Bram RJ, Kay NE, Jelinek DF. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood. 2002;100: 2973-2979.","DOI":"10.1182\/blood-2002-02-0558"},{"key":"2020021218525656000_REF46","doi-asserted-by":"crossref","unstructured":"Munzert G, Kreitmeier S, Bergmann L. Normal structure of NFKB2, C-REL and BCL-3 gene loci in lymphoproliferative and myeloproliferative disorders. Leuk Lymphoma. 2000;38: 395-400.","DOI":"10.3109\/10428190009087031"},{"key":"2020021218525656000_REF47","doi-asserted-by":"crossref","unstructured":"Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2: 465-475.","DOI":"10.1038\/nri844"},{"key":"2020021218525656000_REF48","doi-asserted-by":"crossref","unstructured":"Scapini P, Nardelli B, Nadali G, et al. G-CSF\u2013stimulated neutrophils are a prominent source of functional BLyS. J Exp Med. 2003;197: 297-302.","DOI":"10.1084\/jem.20021343"},{"key":"2020021218525656000_REF49","doi-asserted-by":"crossref","unstructured":"Briones J, Timmerman JM, Hilbert DM, Levy R. BLyS and BLyS receptor expression in nonHodgkin's lymphoma. Exp Hematol. 2002;30: 135-141.","DOI":"10.1016\/S0301-472X(01)00774-3"},{"key":"2020021218525656000_REF50","doi-asserted-by":"crossref","unstructured":"Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol. 2002;168: 5993-5996.","DOI":"10.4049\/jimmunol.168.12.5993"},{"key":"2020021218525656000_REF51","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194: 1625-1638.","DOI":"10.1084\/jem.194.11.1625"},{"key":"2020021218525656000_REF52","doi-asserted-by":"crossref","unstructured":"Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigenexperienced B lymphocytes. Blood. 2002;99: 4087-4093.","DOI":"10.1182\/blood.V99.11.4087"},{"key":"2020021218525656000_REF53","doi-asserted-by":"crossref","unstructured":"Koyama T, Tsukamoto H, Masumoto K, et al. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology (Oxford). 2003;42: 980-985.","DOI":"10.1093\/rheumatology\/keg270"},{"key":"2020021218525656000_REF54","doi-asserted-by":"crossref","unstructured":"Munzert G, Kirchner D, Stobbe H, et al. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B\/Rel-regulated inhibitors of apoptosis. Blood. 2002;100: 3749-3756.","DOI":"10.1182\/blood.V100.10.3749"},{"key":"2020021218525656000_REF55","doi-asserted-by":"crossref","unstructured":"Xu LG, Shu HB. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R\u2013mediated NF-kappa B activation and IL-10 production. J Immunol. 2002;169: 6883-6889.","DOI":"10.4049\/jimmunol.169.12.6883"},{"key":"2020021218525656000_REF56","doi-asserted-by":"crossref","unstructured":"Pelletier M, Thompson JS, Qian F, et al. Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J Biol Chem. 2003;278: 33127-33133.","DOI":"10.1074\/jbc.M305754200"},{"key":"2020021218525656000_REF57","doi-asserted-by":"crossref","unstructured":"Zhou T, Liu W, Zhao L, et al. Therapeutic potential of antagonizing BLyS for chronic lymphocytic leukemia [abstract]. Blood. 2001;98: 808a.","DOI":"10.1182\/blood.V98.6.1979"},{"key":"2020021218525656000_REF58","doi-asserted-by":"crossref","unstructured":"Stohl W. Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein. Curr Opin Rheumatol. 2002; 14: 522-528.","DOI":"10.1097\/00002281-200209000-00007"},{"key":"2020021218525656000_REF59","doi-asserted-by":"crossref","unstructured":"Cheema GS, Roschke V, Hilbert DM, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001;44: 1313-1319.","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S"},{"key":"2020021218525656000_REF60","doi-asserted-by":"crossref","unstructured":"Zhang J, Roschke V, Baker KP, et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol. 2001; 166: 6-10.","DOI":"10.4049\/jimmunol.166.1.6"},{"key":"2020021218525656000_REF61","doi-asserted-by":"crossref","unstructured":"Gross JA, Dillon SR, Mudri S, et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS. Immunity. 2001;15: 289-302.","DOI":"10.1016\/S1074-7613(01)00183-2"},{"key":"2020021218525656000_REF62","doi-asserted-by":"crossref","unstructured":"Gescuk BD, Davis JC Jr. Novel therapeutic agents for systemic lupus erythematosus. Curr Opin Rheumatol. 2002;14: 515-521.","DOI":"10.1097\/00002281-200209000-00006"},{"key":"2020021218525656000_REF63","doi-asserted-by":"crossref","unstructured":"Kalled SL, Ambrose C, Hsu YM. BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders. Expert Opin Ther Targets. 2003;7: 115-123.","DOI":"10.1517\/14728222.7.1.115"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/2\/679\/1694101\/zh800204000679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/2\/679\/1694101\/zh800204000679.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:49:14Z","timestamp":1623412154000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/2\/679\/17817\/Involvement-of-BAFF-and-APRIL-in-the-resistance-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,15]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-02-0540","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,15]]}}}